At that point, GLP-1s become appropriate even below typical BMI thresholds
The OSA Pathway: Zepbound Unaffected One important clarification that gets lost in the Zepbound formulary removal news: the July 2025 CVS Caremark change only affects Zepbound when prescribed for obesity
In the semaglutide arm, risk fell by about 4% per 5 kg lower baseline weight (HR 0.96), whereas this trend was not significant in the placebo arm
Slower absorption When high doses of B12 are injected, the body can only store so much before excess is excreted
Over a period of time, people with high blood sugar can develop serious or life-threatening problems, including heart disease, stroke, kidney problems, nerve damage, and blindness
Muscle Nerve 61 , 436448